Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated ...
Alnylam Pharmaceuticals Logo
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. operates as an early-stage therapeutics company. The Company discovers and develops drug and medicines for the treatment of human disease. Alnylam Pharmaceuticals serves health care sectors in the United States and the United Kingdom.
Address
675 West Kendall Street, Henri A. Termeer Square
Cambridge, 02142
United States
Year founded
2003
Number of employees
2,230
